A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson’s disease patients

BACKGROUND AND PURPOSE: Depressed mood is a common psychiatric problem associated with Parkinson’s disease (PD), and studies have suggested a benefit of rasagiline treatment. METHODS: ACCORDO (see the 1) was a 12-week, double-blind, placebo-controlled trial to evaluate the effects of rasagiline 1 mg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Neurol
Autors principals: Barone, P, Santangelo, G, Morgante, L, Onofrj, M, Meco, G, Abbruzzese, G, Bonuccelli, U, Cossu, G, Pezzoli, G, Stanzione, P, Lopiano, L, Antonini, A, Tinazzi, M
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4676931/
https://ncbi.nlm.nih.gov/pubmed/25962410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.12724
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars